Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation-Reference-Cited by-同舟云学术

Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation

Published:2013-09-01 Issue:25 Volume:31 Page:3158-3161
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Freidlin Boris¹,Sun Zhuoxin¹,Gray Robert¹,Korn Edward L.¹

Affiliation:

1. Boris Freidlin and Edward L. Korn, National Cancer Institute, Bethesda, MD; and Zhuoxin Sun and Robert Gray, Eastern Cooperative Oncology Group, and Dana-Farber Cancer Institute, Boston, MA.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.48.3826

Reference15 articles.

1. Evaluating the Efficiency of Targeted Designs for Randomized Clinical Trials

2. Randomized Phase II Trial Designs With Biomarkers

3. Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges

4. Randomized Clinical Trials With Biomarkers: Design Issues

5. Clinical trials for predictive medicine

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review;Epigenomes;2024-07-15

2. Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial;Biometrics;2024-03-27

3. Dynamic treatment regimens and biomarker-driven strategies: Bridging the two worlds;Comprehensive Precision Medicine;2024

4. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023;Bulletin du Cancer;2023-11

5. Treatment of Early Breast Cancer;Geburtshilfe und Frauenheilkunde;2023-09